<DOC>
	<DOCNO>NCT01580904</DOCNO>
	<brief_summary>The monitoring diabetic pharmacist may contribute effectiveness drug treatment improve quality life . This study measure impact pharmacotherapeutic follow-up diabetic patient . This clinical trial , single blind , control , randomize , conduct two unit pharmacy Brazil . Only intervention group hold pharmacotherapeutic follow use methodology call practice pharmaceutical care , identify resolve problem related drug . The primary outcome glycated hemoglobin , secondary outcome baseline glucose , total cholesterol fraction ( example LDL ) , measure make intervention group control group . Patients follow 24 week , outcome assess 24 week . There confidence interval 95 % significance p &lt; 0.05 , use Student test , chi-square analysis variance ( ANOVA ) others necessary . Expects good result serve model researcher .</brief_summary>
	<brief_title>Impact Pharmaceutical Care Diabetics Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Inclusion criterion : patient age 30 year , diagnose type 2 diabetes , make use oral antidiabetic agent without insulin infectious disease research miss three consecutive interview , suspend hypoglycemic drug medical order</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Pharmaceutical Care</keyword>
	<keyword>Diabetics patient</keyword>
	<keyword>Clinical trial</keyword>
</DOC>